Morgan Stanley 13D and 13G filings for Satsuma Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-04-09 4:50 pm Sale |
2021-03-31 | 13G | Satsuma Pharmaceuticals, Inc. STSA |
MORGAN STANLEY MS |
577,022 1.800% |
-416,601 (-41.93%) |
Filing |
| 2021-02-12 3:59 pm Purchase |
2020-12-31 | 13G | Satsuma Pharmaceuticals, Inc. STSA |
MORGAN STANLEY MS |
993,623 5.700% |
112,185 (+12.73%) |
Filing |
| 2020-12-18 4:27 pm Purchase |
2020-12-11 | 13G | Satsuma Pharmaceuticals, Inc. STSA |
MORGAN STANLEY MS |
881,438 5.100% |
881,438 (New Position) |
Filing |